Antibodies against the N-terminal domain of annexin A2 in antiphospholipid syndrome

European Journal of Internal Medicine

Volumn 23, Issue 7, 2012, Pages 665-668

  Salle, V ^a   Maziere J C ^a   Brule A ^b   Schmidt, J ^a   Smail, A ^a   Duhaut, P ^a   Maziere C ^a   Makdassi, R ^a   Choukroun, G ^a   Betsou, F ^a   Ducroix, J P ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b French Blood Establishment North of France ^*  (France)

Author keywords

Anti annexin A2 antibodies; Antiphospholipid syndrome; Systemic lupus erythematosus

Indexed keywords

ANNEXIN A2 ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOCORTIN 2; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AMINO TERMINAL SEQUENCE; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ANNEXIN A2; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; AUTOANTIGENS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84865685933     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2012.04.006     Document Type: Article

References (27)

1. J.S. Levine, D.W. Branch, and J. Rauch The antiphospholipid syndrome N Engl J Med 346 2002 752 763
2. S.S. Pierangeli, P.P. Chen, E. Raschi, S. Scurati, C. Grossi, and M.O. Borghi Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms Semin Thromb Hemost 34 2008 236 250
3. P.L. Meroni Pathogenesis of the antiphospholipid syndrome: an additional example of the mosaic of autoimmunity J Autoimmun 30 2008 99 103
4. R.T. Urbanus, R.H. Derksen, and P.G. de Groot Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome Blood Rev 22 2008 93 105
5. G. Espinosa, and R. Cervera Antiphospholipid syndrome Arthritis Res Ther 10 2008 230
6. E. Raschi, M.O. Borghi, C. Grossi, V. Broggini, S. Pierangeli, and P.L. Meroni Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome Lupus 17 2008 937 942
7. V. Gerke, and S.E. Moss Annexins: from structure to function Physiol Rev 82 2002 331 371
8. D.M. Waisman Annexin II tetramer: structure and function Mol Cell Biochem 149-150 1995 301 322
9. K.A. Hajjar, and S. Krishnan Annexin II: a mediator of the plasmin/plasminogen activator system Trends Cardiovasc Med 9 1999 128 138
10. E.K. Kristoffersen, and R. Matre Surface annexin II on placental membranes of the fetomaternal interface Am J Reprod Immunol 36 1996 141 149
11. D.J. Falcone, W. Borth, K.M. Khan, and K.A. Hajjar Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II Blood 97 2001 777 784
12. K.A. Hajjar, A.T. Jacovina, and J. Chacko An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II J Biol Chem 269 1994 21191 21197
13. 2-glycoprotein I to human endothelial cells is mediated by annexin II J Biol Chem 275 2000 15541 15548
14. 2 glycoprotein I antibodies Blood 105 2005 1964 1969
15. 2GPI-induced tissue factor expression on monocytes Cell Res 17 2007 737 739
16. Z. Romay-Penabad, M.G. Montiel-Manzano, T. Shilagard, E. Papalardo, G. Vargas, and A.B. Deora Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo Blood 114 2009 3074 3083
17. G. Cesarman-Maus, N.P. Ríos-Luna, A.B. Deora, B. Huang, R. Villa, and C. Cravioto Mdel Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome Blood 107 2006 4375 4382
18. V. Salle, J.C. Mazière, A. Smail, R. Cévallos, C. Mazière, and V. Fuentes Anti-annexin II antibodies in systemic autoimmune diseases and antiphospholipid syndrome J Clin Immunol 28 2008 291 297
19. W. Ao, H. Zheng, X.W. Chen, Y. Shen, and C.D. Yang Anti-annexin II antibody is associated with thrombosis and/or pregnancy morbidity in antiphospholipid syndrome and systemic lupus erythematosus with thrombosis Rheumatol Int 2010
20. K.A. Hajjar, L. Mauri, A.T. Jacovina, F. Zhong, U.A. Mirza, and J.C. Padovan Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine J Biol Chem 273 1998 9987 9993
21. M.C. Hochberg Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 40 1997 1725
22. S. Miyakis, M.D. Lockshin, T. Atsumi, D.W. Branch, R.L. Brey, and R. Cervera International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 4 2006 295 306
23. E.N. Harris, and S.S. Pierangeli 'Equivocal' antiphospholipid syndrome J Autoimmun 15 2000 81 85
24. Y.H. Hong, H.S. Won, H.C. Ahn, and B.J. Lee Structural elucidation of the protein- and membrane-binding properties of the N-terminal tail domain of human annexin II J Biochem 134 2003 427 432
25. Y. Shoenfeld, G. Twig, U. Katz, and Y. Sherer Autoantibody explosion in antiphospholipid syndrome J Autoimmun 30 2008 74 83
26. G.M. Cesarman, C.A. Guevara, and K.A. Hajjar An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation J Biol Chem 269 1994 21198 21203
27. G. Kassam, A. Manro, C.E. Braat, P. Louie, S.L. Fitzpatrick, and D.M. Waisman Characterization of the heparin binding properties of annexin II tetramer J Biol Chem 272 1997 15093 15100